Veracyte Inc (NASDAQ: VCYT) on Monday, plunged -5.12% from the previous trading day, before settling in for the closing price of $32.02. Within the past 52 weeks, VCYT’s price has moved between $18.61 and $47.32.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 32.95% annually for the last half of the decade. The company achieved an average annual earnings per share of 62.37%. With a float of $77.05 million, this company’s outstanding shares have now reached $77.77 million.
In an organization with 824 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 65.97%, operating margin of 3.74%, and the pretax margin is 5.78%.
Veracyte Inc (VCYT) Insider and Institutional Ownership
Observing investor behavior towards Diagnostics & Research industry stocks is more important than anything else. The insider ownership of Veracyte Inc is 1.14%, while institutional ownership is 102.75%. The most recent insider transaction that took place on Mar 07 ’25, was worth 234,630. In this transaction Chief Commercial Officer-CLIA of this company sold 7,411 shares at a rate of $31.66, taking the stock ownership to the 100,249 shares. Before that another transaction happened on Mar 07 ’25, when Company’s Officer proposed sale 7,411 for $32.51, making the entire transaction worth $240,932.
Veracyte Inc (VCYT) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.3 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 62.37% per share during the next fiscal year.
Veracyte Inc (NASDAQ: VCYT) Trading Performance Indicators
Veracyte Inc (VCYT) is currently performing well based on its current performance indicators. A quick ratio of 4.46 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.31. Likewise, its price to free cash flow for the trailing twelve months is 37.11.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.31, a number that is poised to hit 0.03 in the next quarter and is forecasted to reach 0.71 in one year’s time.
Technical Analysis of Veracyte Inc (VCYT)
Let’s dig in a bit further. During the last 5-days, its volume was 1.31 million. That was better than the volume of 0.95 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 12.24%. Additionally, its Average True Range was 2.25.
During the past 100 days, Veracyte Inc’s (VCYT) raw stochastic average was set at 1.68%, which indicates a significant decrease from 2.38% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 81.28% in the past 14 days, which was higher than the 52.64% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $40.36, while its 200-day Moving Average is $33.11. However, in the short run, Veracyte Inc’s stock first resistance to watch stands at $31.50. Second resistance stands at $32.62. The third major resistance level sits at $33.25. If the price goes on to break the first support level at $29.75, it is likely to go to the next support level at $29.12. The third support level lies at $28.00 if the price breaches the second support level.
Veracyte Inc (NASDAQ: VCYT) Key Stats
Market capitalization of the company is 2.37 billion based on 77,945K outstanding shares. Right now, sales total 445,760 K and income totals 24,140 K. The company made 118,630 K in profit during its latest quarter, and 5,110 K in sales during its previous quarter.
